Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reference-based pricing in British Columbia: implications for cardiologists--an analysis

A P Boulet1, G Tessier

  • 1Health Economics Department, Hoechst Marion Roussel Canada Research Inc, Laval, Quebec.

The Canadian Journal of Cardiology
|January 1, 1997
PubMed
Summary

Reference-based pricing (RBP) in British Columbia may increase health care costs by not fully considering therapeutic substitution and patient welfare. Optimal pharmacotherapy requires the right drug, patient, dosage, and timing for cost-effective care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High numerical aperture holographic microscopy reconstruction with extended z range.

Applied optics·2015
Same author

Picometer-scale surface roughness measurements inside hollow glass fibres.

Optics express·2015
Same author

Imaging the three-dimensional scattering pattern of plasmonic nanodisk chains by digital heterodyne holography.

Optics letters·2011
Same author

Multiple wavelength reflectance microscopy to study the multiphysical behavior of microelectromechanical systems.

Optics letters·2011
Same author

Imaging gold nanoparticles in living cell environments using heterodyne digital holographic microscopy.

Optics express·2010
Same author

Photothermal heterodyne holography of gold nanoparticles.

Optics express·2010

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Clinical Pharmacy

Background:

  • Reference-based pricing (RBP) policy funds drug therapies based on the 'gold standard' cost.
  • Pharmacare pays for the lowest cost drug within a cluster, irrespective of indication.
  • Pharmaceutical expenditure is a small, interactive part of the global health care budget.

Purpose of the Study:

  • Analyze the impact of RBP on health care expenditure and patient care.
  • Evaluate the effectiveness of RBP in British Columbia.
  • Consider patient welfare and resource allocation in RBP policy.

Main Methods:

  • Review of international RBP implementation data.
  • Analysis of drug cost-effectiveness and clinical benefits.

Related Experiment Videos

  • Case study: diltiazem dosage forms for hypertension and angina.

    • Main Results:

    • Price controls and restricted drug access may increase, not decrease, health care costs.
    • RBP in British Columbia may not fully address therapeutic substitution's impact on care quality.
    • Optimal pharmacotherapy necessitates a strategy for the right therapy, patient, dosage, and timing.

    Conclusions:

    • RBP policy in British Columbia requires analysis considering patient welfare and resource optimization.
    • Cost containment should not overshadow the importance of therapeutic substitution and quality of care.
    • Effective pharmacotherapy relies on a holistic approach to drug selection and administration.